美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=EPINEPHRINE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
EPINEPHRINE 219239 002 ANDA EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 30MG/30ML (1MG/ML) No No 2025/02/06 2025/10/02 GLAND Prescription
EPINEPHRINE BITARTRATE IN 0.9% SODIUM CHLORIDE 218475 001 NDA EPINEPHRINE BITARTRATE SOLUTION;INTRAVENOUS EQ 16MG BASE/250ML (EQ 64MCG BASE/ML) Yes Yes 2025/02/28 2025/02/28 BAXTER HLTHCARE CORP Prescription
EPINEPHRINE 215425 001 NDA EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS 30MG/30ML (1MG/ML) Yes Yes 2025/03/13 2025/03/13 FRESENIUS KABI USA Prescription
NOREPINEPHRINE BITARTRATE 219443 001 ANDA NOREPINEPHRINE BITARTRATE INJECTABLE;INJECTION EQ 1MG BASE/ML No No 2025/03/21 2025/03/21 BIOCON PHARMA Prescription
EPINEPHRINE 218144 001 ANDA EPINEPHRINE SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS 1MG/ML (1MG/ML) No No 2025/06/03 2025/06/03 GLAND Prescription
EPINEPHRINE 218144 002 ANDA EPINEPHRINE INJECTION;SOLUTION,CONCENTRATE 10MG/10ML No No 2025/06/03 -- GLAND None (Tentative Approval)
EPINEPHRINE 218144 003 ANDA EPINEPHRINE INJECTION;SOLUTION,CONCENTRATE 30MG/30ML No No 2025/06/03 -- GLAND None (Tentative Approval)
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE 219692 001 ANDA NOREPINEPHRINE BITARTRATE SOLUTION;INTRAVENOUS EQ 4MG BASE/250ML (EQ 16MCG BASE/ML) No No 2025/08/11 2025/08/11 SAGENT Prescription
NOREPINEPHRINE BITARTRATE IN 5% DEXTROSE 219692 002 ANDA NOREPINEPHRINE BITARTRATE SOLUTION;INTRAVENOUS EQ 8MG BASE/250ML (EQ 32MCG BASE/ML) No No 2025/08/11 2025/08/11 SAGENT Prescription
EPINEPHRINE 217485 001 ANDA EPINEPHRINE SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS EQ 30MG BASE/30ML (EQ 1MG BASE/ML) No No 2025/10/14 2025/10/14 AMNEAL Prescription
NOREPINEPHRINE BITARTRATE 219924 001 ANDA NOREPINEPHRINE BITARTRATE INJECTABLE;INJECTION EQ 1MG BASE/ML No No 2025/11/25 -- ANTHEA PHARMA Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2025 DrugFuture->U.S. FDA Drugs Database